BTIM Corp. decreased its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 2.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,708 shares of the medical research company’s stock after selling 75 shares during the period. BTIM Corp.’s holdings in Thermo Fisher Scientific were worth $472,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Proficio Capital Partners LLC increased its position in shares of Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after buying an additional 253 shares during the period. Cribstone Capital Management LLC increased its stake in Thermo Fisher Scientific by 8.7% in the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after buying an additional 50 shares during the period. CWM LLC increased its stake in Thermo Fisher Scientific by 17.0% in the second quarter. CWM LLC now owns 710 shares of the medical research company’s stock worth $124,000 after buying an additional 103 shares during the period. Independent Portfolio Consultants Inc. increased its stake in Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock worth $112,000 after buying an additional 2 shares during the last quarter. Finally, Sharkey Howes & Javer increased its stake in Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after buying an additional 7 shares during the last quarter. 87.15% of the stock is currently owned by institutional investors.
Thermo Fisher Scientific Inc (TMO) traded down 1.85% during midday trading on Tuesday, hitting $174.07. The stock had a trading volume of 1,072,827 shares. The company has a market cap of $67.89 billion, a P/E ratio of 30.33 and a beta of 1.06. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $182.87. The stock’s 50-day moving average is $176.88 and its 200-day moving average is $164.14.
Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.03. The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The company’s quarterly revenue was up 10.2% on a year-over-year basis. During the same quarter last year, the business posted $2.03 earnings per share. Equities analysts predict that Thermo Fisher Scientific Inc will post $9.24 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s payout ratio is currently 10.45%.
ILLEGAL ACTIVITY WARNING: “BTIM Corp. Has $472,000 Stake in Thermo Fisher Scientific Inc (NYSE:TMO)” was originally reported by Markets Daily and is the property of of Markets Daily. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.themarketsdaily.com/2017/08/08/btim-corp-has-472000-stake-in-thermo-fisher-scientific-inc-nysetmo-updated.html.
A number of research firms have recently weighed in on TMO. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $197.00 price target for the company in a report on Tuesday, August 1st. BidaskClub lowered Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Bank of America Corporation reiterated a “buy” rating and issued a $210.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. Cleveland Research raised Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Finally, Barclays PLC reaffirmed an “overweight” rating and issued a $200.00 target price (up previously from $190.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 17th. One investment analyst has rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $188.56.
In related news, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction on Monday, June 5th. The shares were sold at an average price of $176.26, for a total transaction of $440,650.00. Following the completion of the transaction, the chief financial officer now owns 37,790 shares of the company’s stock, valued at $6,660,865.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Daniel P. Shine sold 4,688 shares of Thermo Fisher Scientific stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $171.88, for a total transaction of $805,773.44. Following the transaction, the insider now directly owns 29,200 shares of the company’s stock, valued at approximately $5,018,896. The disclosure for this sale can be found here. Insiders have sold 27,188 shares of company stock valued at $4,702,223 in the last ninety days. Insiders own 0.49% of the company’s stock.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.